KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2016 - 2024)

Pacific Biosciences Of California has reported Other Non-Current Liabilities over the past 12 years, most recently at $546000.0 for Q4 2024.

  • Quarterly results put Other Non-Current Liabilities at $546000.0 for Q4 2024, down 27.3% from a year ago — trailing twelve months through Dec 2024 was $546000.0 (down 27.3% YoY), and the annual figure for FY2024 was $546000.0, down 27.3%.
  • Other Non-Current Liabilities for Q4 2024 was $546000.0 at Pacific Biosciences Of California, down from $751000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for PACB hit a ceiling of $200.0 million in Q3 2021 and a floor of $546000.0 in Q4 2024.
  • Median Other Non-Current Liabilities over the past 5 years was $837000.0 (2023), compared with a mean of $33.5 million.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 22327.39% in 2022 and later tumbled 99.59% in 2024.
  • Pacific Biosciences Of California's Other Non-Current Liabilities stood at $752000.0 in 2020, then skyrocketed by 361.57% to $3.5 million in 2021, then tumbled by 62.55% to $1.3 million in 2022, then tumbled by 42.23% to $751000.0 in 2023, then dropped by 27.3% to $546000.0 in 2024.
  • The last three reported values for Other Non-Current Liabilities were $546000.0 (Q4 2024), $751000.0 (Q3 2024), and $751000.0 (Q2 2024) per Business Quant data.